Role of cardiovascular biomarkers for the assessment of mitral stenosis and its complications

Published: 25 May 2016
Author(s): Marc Badoz, Mattia Arrigo, Bernard Iung, Gullu Amioglu, Mehmet Birhan Yilmaz, Nicolas Meneveau, Malha Sadoune, Agnes Brunette, Alexandre Mebazaa, Marie-France Seronde
Issue: May 2016
Section: Original article

Mitral stenosis (MS) may cause progressive dyspnea on exertion, pulmonary hypertension (PH), atrial fibrillation and right ventricular (RV) failure. Patients with MS presenting with change in dyspnea severity often require a complete cardiologic assessment, but the use of biomarkers may be an alternative for the initial assessment of MS and its complications. The aim of this study was to evaluate the role of several cardiovascular biomarkers for this purpose.